胶质瘤临床治疗研究进展综述

Glioma Pub Date : 2020-07-01 DOI:10.4103/glioma.glioma_18_20
Fengping Li, Chao Ma, Cheng-shi Xu, Zhi-yong Pan, Zhiqiang Li
{"title":"胶质瘤临床治疗研究进展综述","authors":"Fengping Li, Chao Ma, Cheng-shi Xu, Zhi-yong Pan, Zhiqiang Li","doi":"10.4103/glioma.glioma_18_20","DOIUrl":null,"url":null,"abstract":"As theories evolve, the mechanism of glioma origination remains poorly understood. Understanding this mechanism promotes the clinical research on glioma therapeutic strategy and then improves the prognosis of patients with glioma. However, the overall survival of these patients is unsatisfactory. In the recent decade, a few novel therapies, such as tumor-treating fields and immunotherapy, have been introduced in clinic. Before they can be widely used, many key factors, including efficacy, safety, and benefit ratio, should be fully evaluated. Therefore, more clinical trials are required to corroborate the results and conclusions of basic research and improve the current treatment strategies. In this article, we searched relevant literature published in the past 5 years in PubMed and China National Knowledge Infrastructure and reviewed the advancements of clinical therapeutic research on glioma.","PeriodicalId":12731,"journal":{"name":"Glioma","volume":"3 1","pages":"119 - 125"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Advancement of clinical therapeutic research on glioma: A narrative review\",\"authors\":\"Fengping Li, Chao Ma, Cheng-shi Xu, Zhi-yong Pan, Zhiqiang Li\",\"doi\":\"10.4103/glioma.glioma_18_20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"As theories evolve, the mechanism of glioma origination remains poorly understood. Understanding this mechanism promotes the clinical research on glioma therapeutic strategy and then improves the prognosis of patients with glioma. However, the overall survival of these patients is unsatisfactory. In the recent decade, a few novel therapies, such as tumor-treating fields and immunotherapy, have been introduced in clinic. Before they can be widely used, many key factors, including efficacy, safety, and benefit ratio, should be fully evaluated. Therefore, more clinical trials are required to corroborate the results and conclusions of basic research and improve the current treatment strategies. In this article, we searched relevant literature published in the past 5 years in PubMed and China National Knowledge Infrastructure and reviewed the advancements of clinical therapeutic research on glioma.\",\"PeriodicalId\":12731,\"journal\":{\"name\":\"Glioma\",\"volume\":\"3 1\",\"pages\":\"119 - 125\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Glioma\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/glioma.glioma_18_20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Glioma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/glioma.glioma_18_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

随着理论的发展,神经胶质瘤起源的机制仍知之甚少。了解这一机制有助于神经胶质瘤治疗策略的临床研究,进而改善神经胶质瘤患者的预后。然而,这些患者的总体生存率并不令人满意。近十年来,一些新的治疗方法,如肿瘤治疗领域和免疫疗法,已被引入临床。在它们被广泛使用之前,应该充分评估许多关键因素,包括疗效、安全性和获益率。因此,需要更多的临床试验来证实基础研究的结果和结论,并改进当前的治疗策略。在这篇文章中,我们检索了PubMed和China National Knowledge Infrastructure在过去5年中发表的相关文献,并回顾了神经胶质瘤临床治疗研究的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Advancement of clinical therapeutic research on glioma: A narrative review
As theories evolve, the mechanism of glioma origination remains poorly understood. Understanding this mechanism promotes the clinical research on glioma therapeutic strategy and then improves the prognosis of patients with glioma. However, the overall survival of these patients is unsatisfactory. In the recent decade, a few novel therapies, such as tumor-treating fields and immunotherapy, have been introduced in clinic. Before they can be widely used, many key factors, including efficacy, safety, and benefit ratio, should be fully evaluated. Therefore, more clinical trials are required to corroborate the results and conclusions of basic research and improve the current treatment strategies. In this article, we searched relevant literature published in the past 5 years in PubMed and China National Knowledge Infrastructure and reviewed the advancements of clinical therapeutic research on glioma.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
12
审稿时长
42 weeks
期刊最新文献
Molecular landscape of glucose metabolism in glioblastoma and the normal human brain: A narrative review Survival trends for patients with primary brain tumors worldwide: What have we learnt? Research progress in the treatment of glioblastoma by an oncolytic virus: A narrative review Current status of clinical application of immunotherapy in the treatment of glioma: A narrative review Scarring, without regeneration, is the therapeutic challenge for making palliative glioma treatments curative
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1